A new AI system that creates simulated cancer genomes could reshape the tools used to analyze tumors, helping bring about ...

While these synthetic genomes are not yet viable for life, they resemble natural DNA, though often with incomplete or nonsensical features—similar to AI-generated images with subtle flaws.

While the concept of creating synthetic life from nothing is still firmly in the science fiction category, synthetic genomes are now reality. Researchers—led by synthetic biologist Hugh Goold of ...

Synthetic genomics has emerged as a transformative field, enabling the design and construction of artificial genomes to explore biological systems and enhance biomanufacturing capabilities. In a ...

A bombshell report revealed a bacteria whose genetic code is said to be more efficient than any other lifeform on earth.

Camena Bioscience (Camena), an innovator in enzymatic DNA synthesis, and Constructive Bio (Constructive), a pioneer in whole genome writing, today announced they have joined a collaborative project ...

Synthetic Genomics, Inc. was founded in 2005 by Venter who was named one of the 100 most influential scientists of 2008 by Time magazine.

Until now, constructing synthetic chloroplast genomes has been extremely challenging due to their structural complexity and very large size.

Two Cambridge-based biotechs, Camena Bioscience and Constructive Bio, have joined a project led by Germany's Max-Planck ...

Investors interested in the Genomics and Synthetic Biology theme should consider these stocks: Twist Bioscience Corporation, Wave Life Sciences, and CRISPR Therapeutics AG.